(Q43256983)

English

Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis

scientific article published on 22 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

cystic fibrosis

0 references

author name string

Yan Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Michael D Tsifansky

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Chia-Jung Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hae In Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Gudrun Schmidt

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yoon Yeo

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

22 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

151-160

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Cystic fibrosis sputum: a barrier to the transport of nanospheres

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9991-2

21 January 2018

Method of evaluating effects of antibiotics on bacterial biofilm

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9991-2

21 January 2018

Aerosolized dornase alpha (rhDNase) in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microparticles for inhalational delivery of antipseudomonal antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of particle sizing techniques in the case of inhalation dry powders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of Pulmozyme (dornase alpha) stability using a kinetic colorimetric DNase I activity assay.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levofloxacin pharmacokinetics in adult cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aerosol antibiotics in cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracellular DNA Required for Bacterial Biofilm Formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacterial biofilms in nature and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aerosolization properties, surface composition and physical state of spray-dried protein powders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of temperature and pH on the solubility of quinolone compounds: estimation of heat of fusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of formulation components on the aerosolisation properties of spray-dried powders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colorimetric determination of DNase I activity with a DNA-methyl green substrate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic testing for cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaceutical particle engineering via spray drying

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracellular barriers in respiratory gene therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trojan particles: large porous carriers of nanoparticles for drug delivery.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nanoparticles for drug delivery to the lungs

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic treatment. Aerosol therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of additives on heat denaturation of rhDNase in solutions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dornase alfa in the treatment of cystic fibrosis in Europe: A report from the Epidemiologic Registry of Cystic Fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro testing of two formoterol dry powder inhalers at different flow rates

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation and physical characterization of large porous particles for inhalation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-009-9991-2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43256983&oldid=1985024483"